Cary.

• Position: Triangle - Cornerstone BioPharma Holdings acquire Boston-based Critical Therapeutics - Brief article

CARY -- Cornerstone BioPharma Holdings, which develops and sells treatments for respiratory diseases, agreed to buy Boston-based Critical Therapeutics for about $63 million. The acquisition, expected to close by the end of the year, will add an asthma drug to Cornerstone's...